Celiker A, Bilgiç A, Karagöz T, Paç A
Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Turk J Pediatr. 2001 Jan-Mar;43(1):59-64.
We report the immediate and short-term results of endovascular stent implantations from our center. We performed stent implantations in four patients (3, 12, 18 and 20 years old) with different stenoses or obstructions: right ventricular outflow conduit obstruction, left Blalock-Taussig obstruction, post-operative recoarctation and cavopulmonary anastomosis obstruction. Stent were implanted successfully. The mean diameters of stenoses were expanded from 4.5 +/- 3.5 (2-7) mm to 9 +/- 1. 2 (8-10) mm, and the complaints of patients were improved significantly by stent implantation. There was no complication related to the procedures. All patients are living except one who died from cerebrovascular event unrelated to the stent implantation. The mean follow-up period of three living patients is 6.3 +/- 5.5 (1-2) months. As of the last control, all have remained at the caliber achieved at original placement. In light of our limited experience and previous reported studies, we conclude that intravascular stents are safe and can be used effectively in selected patients with congenital heart defects.
我们报告了本中心血管内支架植入术的即时和短期结果。我们对4例年龄分别为3岁、12岁、18岁和20岁,患有不同狭窄或阻塞情况的患者进行了支架植入术,这些情况包括右心室流出道梗阻、左布莱洛克 - 陶西格分流术梗阻、术后再狭窄以及腔肺吻合口梗阻。支架均成功植入。狭窄的平均直径从4.5±3.5(2 - 7)毫米扩大至9±1.2(8 - 10)毫米,且支架植入后患者的不适症状明显改善。未发生与手术相关的并发症。除1例因与支架植入无关的脑血管事件死亡外,所有患者均存活。3例存活患者的平均随访期为6.3±5.5(1 - 2)个月。截至最后一次检查,所有患者的血管口径均维持在最初植入时所达到的状态。鉴于我们有限的经验以及先前报道的研究,我们得出结论,血管内支架是安全的,可有效用于特定的先天性心脏病患者。